XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Common Share - Basic and Diluted
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Net Income (Loss) Per Common Share - Basic and Diluted

(3)       Net Income (Loss) Per Common Share - Basic and Diluted

 

For the nine months ended September 30, 2022, the Company had 21,718,500 stock options outstanding, and 4,063 outstanding shares of Series C Preferred Stock, each of which were not included in the computation of diluted income per common share because they would be anti-dilutive. The Company used the treasury stock method in calculating weighted average common shares diluted.

 

For the three months ended September 30, 2022, the Company had 24,868,500 stock options outstanding, and 4,063 outstanding shares of Series C Preferred Stock, each of which were not included in the computation of diluted income (loss) per common share because they would be anti-dilutive. The Company used the treasury stock method in calculating weighted average common shares diluted.

 

For the three and nine months ended September 30, 2021, the Company had 21,102,500 stock options outstanding, 7,065,000 warrants outstanding, 675 outstanding shares of Series B redeemable convertible preferred stock (Series B Preferred Stock), and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were not included in the computation of diluted income (loss) per common share because they would be anti-dilutive.

 

The table below shows the calculation of diluted shares:

                                 
   3 Months Ended   9 Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2022   2021   2022   2021 
Weighted average common shares outstanding - basic   514,789,680    494,635,990    509,587,202    469,627,961 
                     
Effects of dilutive shares                    
Stock Options   —      —      1,470,128    —   
Weighted average common shares outstanding - diluted   514,789,680    494,635,990    511,057,330    469,627,961 

 

The table below summarizes common stock equivalents outstanding at September 30, 2022 and 2021:

               
  September 30, 
   2022   2021 
Stock options   24,868,500    21,102,500 
Warrants         7,065,000 
Shares of Series B redeemable convertible preferred stock         337,500 
Shares of Series C redeemable convertible preferred stock   40,630,000    40,630,000 
    65,498,500    69,135,000